Stay updated on AI Usability in RA: M923 Clinical Trial
Sign up to get notified when there's something new on the AI Usability in RA: M923 Clinical Trial page.

Latest updates to the AI Usability in RA: M923 Clinical Trial page
- Check5 days agoChange DetectedThe completed Phase 3 study record for evaluating an M923 autoinjector in people with moderate to severe rheumatoid arthritis is displayed, with study details, results measures, locations, and supporting documents.SummaryDifference59%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide banner announces NIH website updates and says that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check26 days agoChange DetectedThe 403 Forbidden page’s footer revision label changes from v3.7.1 to v3.7.2; the study record remains inaccessible.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 error instead of the study content, with the content area showing an error screen and navigation elements indicating restricted access.SummaryDifference20%

Stay in the know with updates to AI Usability in RA: M923 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AI Usability in RA: M923 Clinical Trial page.